Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the multiple dose pharmacokinetics of 2
Canagliflozin/extended release Metformin (CANA/MET XR) fixed dose combination tablets (150
mg/1,000 mg each) following once-daily oral dosing in healthy participants.